Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/29/2009CA2721260A1 Isoquinolinone derivatives as nk3 antagonists
10/29/2009CA2721013A1 Transdermal therapeutic system for administration of fentanyl or an analogue thereof
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/29/2009CA2720659A1 1-(7-(hexahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)quinolin-4-yl)-3-(pyrazin-2-yl)urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
10/29/2009CA2720658A1 Improved formulations for poorly permeable active pharmaceutical ingredients
10/29/2009CA2720654A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009CA2720479A1 Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel
10/29/2009CA2720357A1 Fused pyrimidineone compounds as trpv3 modulators
10/29/2009CA2719936A1 Substituted pyrimidin-5-carboxamides 281
10/28/2009EP2112228A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
10/28/2009EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/28/2009EP2112170A1 Cellulose derivative and method for production thereof
10/28/2009EP2112167A2 Humanized ANTI-ERBB2 antibodies and treatment with ANTI-ERBB2 antibodies
10/28/2009EP2112155A1 Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation
10/28/2009EP2112154A1 Esters in position 20 of camptothecins
10/28/2009EP2112152A1 Dihydropteridinones as Plk Inhibitors
10/28/2009EP2112151A2 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/28/2009EP2112150A1 Improved raf inhibitors
10/28/2009EP2112148A1 Solid salt forms of a pyrrole substituted 2-indolinone
10/28/2009EP2112145A1 Chromenone derivatives useful for the treatment of neurodegenerative diseases
10/28/2009EP2112142A1 Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP2112134A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/28/2009EP2111870A1 Dosages for treatment of anti-erbB2 antibodies
10/28/2009EP2111865A1 Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
10/28/2009EP2111864A2 Therapeutic methods and uses of sapogenins and their derivatives
10/28/2009EP2111863A1 Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
10/28/2009EP2111862A1 Pharmaceutical product for prevention and treatment of alzheimer's dementia
10/28/2009EP2111861A1 Compositions of phosphodiesterase type IV inhibitors
10/28/2009EP2111860A1 Inflammation inhibitor comprising zinc salt of acylamino acid
10/28/2009EP2111859A1 5HT2C receptor modulator compositions and methods of use
10/28/2009EP2111858A1 Novel treatment for alzheimer's disease
10/28/2009EP2111857A1 Transdermal therapeutic system for application of fentanyl or an analogue material thereof
10/28/2009EP2111855A1 Antibacterial compositions for the treatment of infections of the upper and lower airways
10/28/2009EP2111416A1 Iron-hydrocarbon complex compounds
10/28/2009EP2111409A1 Novel cationic 17 alpha- substituted-estradiol derivatives useful as anti-cancer agent
10/28/2009EP2111406A1 Substituted spirochromanone derivatives as acc inhibitors
10/28/2009EP2111403A1 Triazabenzo[e]azulene derivatives for the treatment of tumors
10/28/2009EP2111402A2 Aminopyrazole kinase inhibitors
10/28/2009EP2111401A1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
10/28/2009EP2111400A1 Pyridine compounds and their use as p2y12 antagonists.
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP2111396A1 Hcv inhibiting macrocyclic phenylcarbamates
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP2111394A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
10/28/2009EP2111391A1 New unsaturated fatty amino-acid derivatives and use thereof in dermal cosmetology
10/28/2009EP2111387A1 New method for preparing unsaturated fatty hydroxy-acids
10/28/2009EP2111262A2 1,3-dihydroimidazoles for treating cardiovascular disorders
10/28/2009EP2111231A2 Methods and compositions for improving immune responses
10/28/2009EP2111226A2 Cyclitols and their derivatives and their therapeutic applications
10/28/2009EP2111225A2 Inhibition of ppar gamma expression by specific osteogenic oxysterols
10/28/2009EP2111224A2 Targeting ncca-atp channel for organ protection following ischemic episode
10/28/2009EP2111126A1 Improved stability in vitamin and mineral supplements
10/28/2009EP2111125A2 Liquid formulations
10/28/2009EP2111108A2 (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
10/28/2009EP2111107A2 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
10/28/2009EP2034958B1 Stable aqueous suspension having palatable taste
10/28/2009EP1998750B1 Mucosal bioadhesive slow release carrier for delivering active principles
10/28/2009EP1976538B1 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
10/28/2009EP1915129B1 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
10/28/2009EP1898882B1 Nanoparticulate ebastine formulations
10/28/2009EP1865966B1 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
10/28/2009EP1828207B1 Thiazolopyridinone derivates as mch receptor antagonists
10/28/2009EP1811841B1 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
10/28/2009EP1786779B1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
10/28/2009EP1765343B1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
10/28/2009EP1758469B1 Improvement of barrier integrity in hiv patients by use of fatty acids
10/28/2009EP1753997B1 Photochromic material comprising a proteorhodopsin apoprotein and retinal analog
10/28/2009EP1745052B9 Hiv integrase inhibitors: cyclic pyrimidinone compounds
10/28/2009EP1734959B1 Compounds for treating schizophrenia and/or glucoregulatory abnormalities
10/28/2009EP1732557B1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
10/28/2009EP1718747B1 Stabilized rnas as transfection controls and silencing reagents
10/28/2009EP1696914B1 3-cyano-quinoline derivatives with antiproliferative activity
10/28/2009EP1663247B1 Use of oxcarbazepine for the improvement of sleep in patients suffering from chronic pain
10/28/2009EP1660066B1 Pharmaceutical composition comprising a combination of metformin and a statin
10/28/2009EP1656122B1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease
10/28/2009EP1633717B1 P2x7 receptor antagonists and their use
10/28/2009EP1631548B1 Inhibitors of akt activity
10/28/2009EP1624936B1 Cns chloride modulation and uses thereof
10/28/2009EP1611126B1 Chromenone indoles
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
10/28/2009EP1408967B1 PHARMACEUTICAL COMPOSITIONS BASED ON Tiotropium, Ciclesonide AND a BETAMIMETIC AGENT FOR THE TREATMENT OF INFLAMMATORY AND/OR OBSTRUCTIVE RESPIRATORY TRACT DISEASES
10/28/2009EP1404323B1 Use of methylnaltrexone to treat immune suppression
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1371640B1 Novel a-lipoic acid derivative and use thereof
10/28/2009EP1346218B1 Tripeptide of fc gamma riia
10/28/2009EP1301185B1 Anthelminthic agents for the prevention of parasitic infections in humans and animals
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009EP1214057B1 Vascular coating composition
10/28/2009EP1150666B1 Gm-csf for the treatment of crohn's disease
10/28/2009EP0975340B2 Therapeutic inhibitor of vascular smooth muscle cells
10/28/2009CN101568639A Medium supplement for virus production
10/28/2009CN101568547A Substituted estratrien derivatives as 17beta hsd inhibitors
10/28/2009CN101568544A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
10/28/2009CN101568543A Macrocyclic peptides as hepatitis c virus inhibitors
10/28/2009CN101568541A Spirocyclic azaadamantane derivatives and methods of use
10/28/2009CN101568540A Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/28/2009CN101568539A Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
10/28/2009CN101568538A Thiophene analogues for the treatment or prevention of flavivirus infections
1 ... 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 ... 7860